The estimated Net Worth of Tonia L Pankopf is at least $203 Tisíc dollars as of 31 December 2021. Ms. Pankopf owns over 683 units of Lifecore Biomedical Inc stock worth over $37,388 and over the last 11 years she sold LNDC stock worth over $0. In addition, she makes $165,917 as Independent Director at Lifecore Biomedical Inc.
Tonia has made over 15 trades of the Lifecore Biomedical Inc stock since 2014, according to the Form 4 filled with the SEC. Most recently she bought 683 units of LNDC stock worth $5,000 on 31 December 2021.
The largest trade she's ever made was exercising 5,627 units of Lifecore Biomedical Inc stock on 7 August 2015 worth over $73,657. On average, Tonia trades about 1,906 units every 102 days since 2013. As of 31 December 2021 she still owns at least 4,268 units of Lifecore Biomedical Inc stock.
You can see the complete history of Ms. Pankopf stock trades at the bottom of the page.
Tonia Pankopf serves as Independent Director of the Company. Ms. Pankopf has served as a member of the Board of Directors since November 2012. Ms. Pankopf has been managing partner of Pareto Advisors, LLC since 2005. Previously, she was a senior analyst and managing director at Palladio Capital Management from January 2004 through April 2005. From 2001 to 2003, Ms. Pankopf served as an analyst and portfolio manager with P.A.W. Capital Partners, LP. Ms. Pankopf was a senior analyst and vice president at Goldman, Sachs & Co. from 1999 to 2001 and at Merrill Lynch & Co. from 1998 to 1999. From November 2003 until July 2017, she was a member of the board of directors of TICC Capital Corp, a business development company, having served on its Audit, Valuation, Nominating and Corporate Governance Committees and chairing its Compensation Committee. Ms. Pankopf served on the Board of the University System of Maryland Foundation from 2006 to 2012. Ms. Pankopf is a member of the NACD and is an NACD Board Leadership Fellow.
As the Independent Director of Lifecore Biomedical Inc, the total compensation of Tonia Pankopf at Lifecore Biomedical Inc is $165,917. There are 10 executives at Lifecore Biomedical Inc getting paid more, with Dr. Albert D. Bolles Ph.D. having the highest compensation of $989,459.
Tonia Pankopf is 53, she's been the Independent Director of Lifecore Biomedical Inc since 2012. There are 17 older and 2 younger executives at Lifecore Biomedical Inc. The oldest executive at Lifecore Biomedical Inc is Charles Macaluso, 76, who is the Independent Director.
Tonia's mailing address filed with the SEC is C/O LANDEC CORPORATION, 2811 AIRPARK DRIVE, SANTA MARIA, CA, 93455.
Over the last 21 years, insiders at Lifecore Biomedical Inc have traded over $49,493,033 worth of Lifecore Biomedical Inc stock and bought 1,245,307 units worth $12,385,872 . The most active insiders traders include Nicholas Tompkins, Partners Small Cap Value Lp... a Gary T Steele. On average, Lifecore Biomedical Inc executives and independent directors trade stock every 17 days with the average trade being worth of $253,944. The most recent stock trade was executed by Partners Small Cap Value Lp... on 24 October 2022, trading 250,000 units of LNDC stock currently worth $2,022,500.
Landec Corporation is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc.Landec designs, develops, manufactures and sells products for the food and biopharmaceutical industry. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market.
Lifecore Biomedical Inc executives and other stock owners filed with the SEC include: